27.27
2.19%
-0.61
Royalty Pharma plc (RPRX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
11.14%
596.07
|
536.31 | 538.20 | 683.97 | 565.75 |
Operating Expenses
|
104.37%
-16.83
|
384.87 | 289.36 | 205.00 | 1,048.40 |
Interest Income/Expense |
2.65%
47.26
|
46.03 | 46.95 | 46.95 | 46.95 |
Benefits Costs and Expenses |
129.34%
-121.52
|
414.24 | 186.87 | 174.88 | 1,175.78 |
Costs And Expenses |
104.37%
-16.83
|
384.87 | 289.36 | 205.00 | 1,048.40 |
Provision For Loan, Lease, And Other Losses |
130.49%
-9.12
|
29.91 | -5.922 | 7.415 | -312.37 |
Operating Income/Loss |
304.71%
612.90
|
151.44 | 248.84 | 478.97 | -482.65 |
Nonoperating Income/Loss |
456.51%
104.69
|
-29.36 | 102.50 | 30.12 | -127.38 |
Income/Loss Before Equity Method Investments |
463.49%
717.32
|
127.30 | 352.11 | 474.48 | -603.17 |
Income/Loss From Equity Method Investments |
105.13%
0.268
|
-5.222 | -0.77 | 34.61 | -6.856 |
Income/Loss From Continuing Operations Before Tax |
487.81%
717.59
|
122.08 | 351.34 | 509.09 | -610.03 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
487.81%
717.59
|
122.08 | 351.34 | 509.09 | -610.03 |
Net Income/Loss
|
487.81%
717.59
|
122.08 | 351.34 | 509.09 | -610.03 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
346.82%
223.25
|
49.96 | 123.71 | 168.33 | -153.95 |
Basic Average Shares |
100.13%
-0.561
|
448.44 | 450.40 | 445.61 | 1.421 |
Diluted Average Shares |
100.30%
-1.817
|
601.14 | 605.86 | 607.25 | -169.24 |
Basic Earnings Per Share |
593.75%
1.11
|
0.16 | 0.51 | 0.76 | -1.04 |
Diluted Earnings Per Share |
587.50%
1.10
|
0.16 | 0.50 | 0.76 | -1.04 |
Common Stock Dividends |
0.00%
0.20
|
0.20 | 0.20 | 0.20 | 0.19 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):